Live
- Gentle in manner, resolute in convictions: Sonia Gandhi pens emotional note for Dr. Manmohan Singh
- 2024: A landmark year for India's defence achievements and breakthroughs
- 2025 Horoscopes: Insights and Guidance by Pt. Umesh Chandra Pant
- Osamu Suzuki was a legendary figure in global auto industry: PM Modi
- “AMOEBA”: Celebrating the Journey of Telugu Entrepreneur Sri Motaparti Siva Rama Vara Prasad
- Sachin Khedekar recites a poem from director Feroz Abbas Khan’s powerful new play, ‘Hind 1957’
- NABL-QCI appoints Dr. Sandip Shah as chairperson
- Centre transfers Rs 2.23 lakh crore for 1,206 schemes under Direct Benefit Transfer
- BGT 2024-25: Watching Konstas bat reminds me of Symonds, says Hayden
- 75 iconic lighthouses in India saw more than 10 lakh visitors till September
Reduced price of meds should be implemented
The National Pharmaceutical Pricing Authority imposed a ceiling on the prices of 651 medicines
Visakhapatnam: Consumer Organisations Federation (COF) state president Kandregula Venkata Ramana has appealed for immediate implementation of the directives issued by the Central government reducing the prices of 651 regular medicines.
Speaking to the media here on Thursday, he stated that the orders came into effect from April 1 but it is yet to be implemented in Andhra Pradesh. The National Pharmaceutical Pricing Authority (NPPA) has imposed a ceiling on the prices of 651 medicines, which will reduce the prices by 6.73 percent across the country, he added.
About Rs 3,500 crore financial burden can be reduced by reducing the price of these medicines, he said.
However, Venkata Ramana objected that even though the prices have come down, the shopkeepers are currently exploiting the consumers by selling at the premium prices as before. He demanded that the drug manufacturers should declare the price list of medicines through the Integrated Pharmaceutical Database Management System (IPDMS).
Venkata Ramana mentioned in the petition to the health department that every retailer and dealer should display the drug prices in the business premises visible to the consumers.
